- Directors’ / PDMR Dealing and Grant of Options
- Results for the Year ended 31 December 2023
- Notice of Results and Investor Presentation
- Eroxon to be available on prescription
- Trading Update
- Appointment of Joint Corporate Broker
- Director/PDMR Dealing
- Remuneration of Non-Exec Directors & Voting Rights
- Futura Medical extends collaboration with Cooper
- Appointment of Roy Davis as Non-Executive Director
More ▼
Key statistics
As of last trade, Futura Medical PLC (FAMDF:PKC) traded at 0.42, 180.00% above the 52 week low of 0.150 set on Nov 06, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.42 |
---|---|
High | 0.42 |
Low | 0.40 |
Bid | -- |
Offer | -- |
Previous close | 0.42 |
Average volume | 6.57k |
---|---|
Shares outstanding | 301.45m |
Free float | 202.32m |
P/E (TTM) | -- |
Market cap | 105.06m GBP |
EPS (TTM) | -0.0219 GBP |
Data delayed at least 15 minutes, as of Apr 29 2024 20:50 BST.
More ▼